STUDY OF HOMEOPATHIC MEDICINES FOR CHILDREN WITH MILD TO MODERATE ADENOID PROBLEMS

A Randomized Single Blind Clinical trial Comparing the efficacy of Individualized Homoeopathic Medicine versus Agraphis Nutans 6C in pediatric Adenoid Hypertrophy Grade I and Grade II. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/095063

Enrollment

Registered

2025-09-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J352- Hypertrophy of adenoids

Interventions

Intervention1: Individualised Homoeopathic Medicine: Along with standard medical care, patients will receive an individualised homoeopathic remedy prescribed according to classical homeopathic princip

Eligibility

Inclusion criteria

Inclusion criteria: Prediagnosed cases Grade I and Grade II Adenoid Hypertrophy. Persistent symptoms of nasal obstruction,snoring,or mouth breathing lasting for more than 3 months.

Exclusion criteria

Exclusion criteria: Previous adenoidectomy Use of nasal corticosteroid within 1 month Craniofacial anomalies or neuromuscular disorder Grade III and Grade IV adenoid hypertrophy complications Nasal polyp Nasal obstruction due to anatomic malformations (i.e.choanal atresia or diaphragm,septal deviations etc.)

Design outcomes

Primary

Measure	Time frame
To evaluate quality of life changes in comparative study of individualised homoeopathic medicine versus Agraphis Nutans 6C using the OSA-18 questionnaireTimepoint: Quality of life assessed using the OSA-18 questionnaire at baseline and at end of 18 months study period.	—

Secondary

Measure	Time frame
Assessment of severity (mild, moderate, severe) to compare the reduction in adenoids size between individualised homoeopathic medicines and agraphis nutans 6CTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDrSameer SNadgauda

BVDUHMC

sameer.nadgauda@bharatividyapeeth.edu9970153078

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026